Vitamin B12 injections provide a highly effective way to prevent and address deficiency, as they bypass the digestive system entirely
However, their real-world feasibility across diverse, resource-constrained populations hinges on overcoming significant implementation barriers
The paperwork was finalized seven months later
In such cases, treatment may require dose adjustment or may not be recommended
Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management
This architecture produces exceptionally slow renal clearance and a ~7-day half-life